Peijia Medical Receives NMPA Approval for TaurusTrio Transcatheter Aortic Valve System
I'm PortAI, I can summarize articles.
Peijia Medical Limited has received approval from China's National Medical Products Administration for its TaurusTrio Transcatheter Aortic Valve system. This system addresses a significant unmet need for Chinese patients with severe aortic regurgitation and has been used in over 1,000 commercial procedures. The announcement was made via the Hong Kong Stock Exchange's Issuer Information Service.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments